Verona Pharma plc
VRNADelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001657312
Verona Pharma plc was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 243 institutions reported holding it in 13F filings for Q3 2025, worth $8.57B in total; superinvestors Duquesne Family Office and Soros Fund Management held it.
13F holders, Q2 2024
Institutional positions in Verona Pharma plc as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 125
- +13 vs. Q1 2024
- Shares held
- 66.2M
- −775.6K (−1.2%) vs. Q1 2024
- Total value
- $957.0M
- −$127.9M (−11.8%) vs. Q1 2024
- New holders
- 26
- 44 more added
- Sold out
- 13
- 33 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VRNA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $359.0K |
| Q3 2025 | 243 | $8.57B |
| Q2 2025 | 292 | $7.18B |
| Q1 2025 | 258 | $4.58B |
| Q4 2024 | 191 | $3.19B |
| Q3 2024 | 150 | $1.95B |
| Q2 2024 | 125 | $957.0M |
| Q1 2024 | 113 | $1.08B |
| Q4 2023 | 117 | $1.35B |
| Q3 2023 | 102 | $1.07B |
| Q2 2023 | 105 | $1.33B |
| Q1 2023 | 95 | $1.21B |
| Q4 2022 | 88 | $1.31B |
| Q3 2022 | 68 | $529.0M |
| Q2 2022 | 40 | $145.9M |
| Q1 2022 | 39 | $181.7M |
| Q4 2021 | 42 | $248.0M |
| Q3 2021 | 40 | $202.7M |
| Q2 2021 | 37 | $239.9M |
| Q1 2021 | 37 | $305.1M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Verona Pharma plc; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Candriam Luxembourg S.C.A. | 772,997 | $11.2M | 0.07% | +772,997 | New |
| Boothbay Fund Management, LLC | 855,398 | $12.4M | 0.40% | +216,280+33.8% | Added |
| Morgan Stanley | 864,031 | $12.5M | 0.00% | +530,859+159.3% | Added |
| American Century Companies Inc | 878,043 | $12.7M | 0.01% | +317,184+56.6% | Added |
| Rice Hall James & Associates, LLC | 939,576 | $13.6M | 0.81% | +263,819+39.0% | Added |
| Price T Rowe Associates Inc | 949,375 | $13.7M | 0.00% | +949,375 | New |
| Laurion Capital Management LP | 1,050,842 | $15.2M | 0.50% | +168,802+19.1% | Added |
| Hood River Capital Management LLC | 1,062,456 | $15.4M | 0.32% | +74,700+7.6% | Added |
| Janus Henderson Group PLC | 1,092,042 | $15.8M | 0.01% | −939,952−46.3% | Reduced |
| Aisling Capital Management LP | 1,115,352 | $16.1M | 6.98% | 00.0% | Unchanged |
| Jennison Associates LLC | 1,128,032 | $16.3M | 0.01% | −465,801−29.2% | Reduced |
| Bellevue Group AG | 1,134,229 | $16.4M | 0.27% | −5,066−0.4% | Reduced |
| Wellington Management Group LLP | 1,571,360 | $22.7M | 0.00% | −2,338,106−59.8% | Reduced |
| Caligan Partners LP | 1,843,756 | $26.7M | 6.23% | +547,309+42.2% | Added |
| Octagon Capital Advisors LP | 1,895,200 | $27.4M | 4.52% | −473,800−20.0% | Reduced |
| Federated Hermes, Inc. | 2,163,600 | $31.3M | 0.07% | −95,000−4.2% | Reduced |
| Perceptive Advisors LLC | 2,433,725 | $35.2M | 0.85% | −1,327,851−35.3% | Reduced |
| Carlyle Group Inc. | 2,457,500 | $35.5M | 3.37% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 2,861,801 | $41.4M | 0.88% | −536,266−15.8% | Reduced |
| Maverick Capital LtdSuperinvestorMaverick Capital | 3,092,807 | $44.7M | 0.85% | +1,316,998+74.2% | Added |
| Frazier Life Sciences Management, L.P. | 3,314,349 | $47.9M | 2.24% | +300,000+10.0% | Added |
| Vivo Capital, LLC | 3,549,758 | $51.3M | 4.74% | −60,419−1.7% | Reduced |
| Deep Track Capital, LP | 4,000,000 | $57.8M | 1.73% | +812,585+25.5% | Added |
| NEA Management Company, LLC | 5,584,753 | $80.8M | 6.08% | +476,190+9.3% | Added |
| Ra Capital Management, L.P. | 7,632,646 | $110.4M | 1.46% | +1,314,656+20.8% | Added |
| First Turn Management, LLC | 0 | $0 | 0.00% | −973,130−100.0% | Sold out |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −736,738−100.0% | Sold out |
| AXA S.A. | 0 | $0 | 0.00% | −277,784−100.0% | Sold out |
| Superstring Capital Management LP | 0 | $0 | 0.00% | −259,383−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −96,500−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −36,305−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −29,676−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −25,616−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −23,180−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −13,682−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −2,458−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −657−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Cutler Group LP | – | – | – | – | Not filed |